News & Articles

Results per page

9 Articles Found | Selected Filters:

Personal Genome Diagnostics Inc. (PDGx)Clear Filters

Plasma-Based Companion Diagnostic Assay for Targeted Immuno-Oncology Drug Candidate Bemarituzumab

Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers

3 Apr 2018

Industry NewsLife Sciences

Liquid Biopsy Assay Assesses Microsatellite Instability Status to Identify Patients that will Benefit from Immuno-Oncology Treatment

28 Mar 2017

Industry NewsLife Sciences

New Genomic Analysis Technology Has Been Used to Demonstrate How Cancer Drug Resistance Evolves

5 Jan 2017

Industry NewsLife Sciences

New Genome Test for Pan-Cancer Tumor Profiling

20 Dec 2016

Industry NewsClinical Diagnostics

Positive Data for Liquid Biopsy Genomic Testing in Small Cell Lung Cancer Patients

18 Sept 2016

Industry NewsLife Sciences

Personal Genome Diagnostics Collaborates on Study Uncovering New Actionable Mutations and Prognostic Predictors in Pancreatic Cancer.

Study in Nature Communications identifies new predictors of patient outcome and suggests targeted therapy approaches may benefit more patients than previously thought.

8 Jul 2015

Product NewsLife Sciences

Personal Genome Diagnostics Raises $2.8 Million and Launches its METDetect Assay to Detect MET Gene Amplifications from Circulating Tumor DNA

8 Apr 2014

Product NewsLife Sciences

Personal Genome Diagnostics Licences Technology from Johns Hopkins University for Improved Detection of Cancer Mutations in Circulating DNA

24 Jan 2014

Product NewsLife Sciences

Personal Genome Diagnostics and Blueprint Medicines Collaborate to Identify Novel Kinase Cancer Targets

21 May 2013

News & Articles

Results per page

Articles Filter

Field

Technique

Company

Type of Content

9 Articles Found | Selected Filters:

Plasma-Based Companion Diagnostic Assay for Targeted Immuno-Oncology Drug Candidate Bemarituzumab

Liquid Biopsy Assay Assesses Microsatellite Instability Status to Identify Patients that will Benefit from Immuno-Oncology Treatment

New Genomic Analysis Technology Has Been Used to Demonstrate How Cancer Drug Resistance Evolves

New Genome Test for Pan-Cancer Tumor Profiling

Positive Data for Liquid Biopsy Genomic Testing in Small Cell Lung Cancer Patients

Personal Genome Diagnostics Collaborates on Study Uncovering New Actionable Mutations and Prognostic Predictors in Pancreatic Cancer.

Personal Genome Diagnostics Raises $2.8 Million and Launches its METDetect Assay to Detect MET Gene Amplifications from Circulating Tumor DNA

Personal Genome Diagnostics Licences Technology from Johns Hopkins University for Improved Detection of Cancer Mutations in Circulating DNA

Personal Genome Diagnostics and Blueprint Medicines Collaborate to Identify Novel Kinase Cancer Targets

News & Articles

Results per page

Articles FilterArticles Filter

Field

Technique

Company

Type of Content

9 Articles Found | Selected Filters:

Plasma-Based Companion Diagnostic Assay for Targeted Immuno-Oncology Drug Candidate Bemarituzumab

Liquid Biopsy Assay Assesses Microsatellite Instability Status to Identify Patients that will Benefit from Immuno-Oncology Treatment

New Genomic Analysis Technology Has Been Used to Demonstrate How Cancer Drug Resistance Evolves

New Genome Test for Pan-Cancer Tumor Profiling

Positive Data for Liquid Biopsy Genomic Testing in Small Cell Lung Cancer Patients

Personal Genome Diagnostics Collaborates on Study Uncovering New Actionable Mutations and Prognostic Predictors in Pancreatic Cancer.

Personal Genome Diagnostics Raises $2.8 Million and Launches its METDetect Assay to Detect MET Gene Amplifications from Circulating Tumor DNA

Personal Genome Diagnostics Licences Technology from Johns Hopkins University for Improved Detection of Cancer Mutations in Circulating DNA

Personal Genome Diagnostics and Blueprint Medicines Collaborate to Identify Novel Kinase Cancer Targets

Articles Filter